A 10-month-old kitten with methylmalonic aciduria—a rare genetic metabolic disease—showed severe neurological decline including loss of coordination, seizures, and vision problems caused by extremely low vitamin B12 levels and abnormal metabolic waste accumulation. According to Gram Research analysis of this case report, the kitten had marked brain shrinkage visible on MRI scans and widespread nerve cell death confirmed at autopsy, demonstrating how this metabolic disorder causes progressive and severe damage to the nervous system even with vitamin B12 supplementation and dietary treatment.
A 10-month-old kitten developed a serious but rare genetic disease called methylmalonic aciduria, which affects how the body processes certain nutrients. The kitten showed signs like loss of coordination, seizures, and vision problems. Doctors found that the kitten had very low vitamin B12 levels and unusual chemicals in its urine. Even with vitamin B12 supplements and special food, the kitten’s condition got worse. After the kitten died, doctors found severe damage to the brain and other organs. This case helps veterinarians understand this uncommon disease better and shows how important proper nutrient metabolism is for brain health.
Key Statistics
A 2026 case report in the Journal of Veterinary Internal Medicine documented a 10-month-old domestic shorthair kitten with methylmalonic aciduria showing marked hypocobalaminemia (extremely low vitamin B12) and abnormal urinary metabolites including methylmalonic acid, methylcitrate, and propionylglycine.
MRI imaging in the affected kitten revealed generalized cerebral and cerebellar atrophy with mild ventriculomegaly, indicating significant brain shrinkage and fluid accumulation despite vitamin B12 supplementation and dietary modification.
Post-mortem examination of the kitten with methylmalonic aciduria showed multiorgan and central nervous system changes characterized by neuronal degeneration, necrosis, cortical atrophy, and globular eosinophilic intracytoplasmic material within neurons, confirming severe metabolic damage to brain tissue.
The Quick Take
- What they studied: A single kitten with a rare genetic disease that prevents the body from properly using vitamin B12, causing severe neurological problems
- Who participated: One 10-month-old domestic shorthair kitten with progressive neurological symptoms
- Key finding: The kitten had extremely low vitamin B12 levels and abnormal metabolic byproducts in urine, combined with brain shrinkage visible on MRI scans
- What it means for you: This case is important for cat owners and veterinarians to recognize rare metabolic diseases early. If your kitten shows unexplained neurological problems like loss of coordination or seizures, ask your vet about metabolic testing. This is a rare condition, but early diagnosis might help in future cases.
The Research Details
This is a case report, which means doctors documented one patient’s medical journey in detail. The kitten was examined multiple times with different tests including blood work, urine analysis, and brain imaging (MRI). The doctors measured vitamin B12 levels and checked for unusual chemicals in the urine that indicate metabolic problems. After the kitten died, they performed a necropsy (animal autopsy) to examine the brain and organs under a microscope. This detailed approach helped them understand what was happening at every level—from blood chemistry to actual tissue damage.
Case reports are valuable for identifying rare diseases that doctors might otherwise miss. By documenting this kitten’s complete medical picture, veterinarians can now recognize similar patterns in other animals. The combination of clinical signs, lab results, imaging findings, and tissue examination provides a complete picture of how this rare disease progresses and damages the body.
This is a single case report, which is the lowest level of research evidence but valuable for rare diseases. The strength comes from thorough documentation including multiple diagnostic tests, imaging studies, and microscopic examination of tissues. However, conclusions about treatment effectiveness are limited since there’s only one patient. The findings are most useful for helping veterinarians recognize similar cases in the future.
What the Results Show
The kitten presented with progressive neurological problems starting around 10 months of age. The main symptoms included ataxia (loss of coordination and balance), episodic opisthotonus (severe muscle rigidity and arching), impaired vision, difficulty swallowing, and seizures. Blood tests revealed markedly low vitamin B12 levels—much lower than normal. Urine tests showed abnormally high levels of methylmalonic acid, methylcitrate, and propionylglycine, which are metabolic waste products that accumulate when the body cannot properly process certain nutrients. Brain imaging (MRI) showed that the kitten’s brain and cerebellum (the part controlling coordination) had shrunk, and the fluid-filled spaces in the brain were enlarged.
The post-mortem examination revealed extensive damage throughout the nervous system and other organs. Microscopic examination showed neuronal degeneration and necrosis (nerve cell death), cortical atrophy (shrinkage of the brain’s outer layer), and globular eosinophilic intracytoplasmic material within neurons (abnormal protein accumulation inside nerve cells). There was also gliosis, which means the brain’s support cells had proliferated in response to nerve cell damage. These findings confirmed that the metabolic disorder had caused widespread and severe damage to the central nervous system.
Methylmalonic aciduria is an extremely rare metabolic disorder in cats. This case report adds to the limited veterinary literature on this disease. In humans, similar conditions are better documented, but this kitten case provides important information about how the disease progresses in felines. The combination of clinical signs, biochemical abnormalities, and imaging findings matches what would be expected from cobalamin metabolism defects, helping confirm the diagnosis in an animal species where such cases are rarely documented.
This is a single case report, so findings cannot be generalized to all cats with similar symptoms. The kitten died before long-term treatment outcomes could be evaluated, so we don’t know if different treatment approaches might have been more effective. The exact genetic mutation causing the disease was not identified through DNA testing. Additionally, this case represents an extremely rare condition, so it may not be directly applicable to other animals unless they have identical genetic defects.
The Bottom Line
For veterinarians: Consider methylmalonic aciduria in kittens presenting with progressive neurological signs, especially when accompanied by low vitamin B12 and abnormal urinary metabolites. Vitamin B12 supplementation and dietary modification are reasonable initial treatments, though this case suggests they may not be sufficient for severe forms. For cat owners: If your kitten shows unexplained neurological problems, ask your veterinarian about metabolic screening. Early diagnosis of rare metabolic diseases may improve outcomes in future cases.
Veterinarians caring for kittens with unexplained neurological symptoms should be aware of this condition. Cat breeders and owners of kittens showing progressive neurological decline should discuss metabolic testing with their veterinarian. This is particularly relevant for domestic shorthair cats, though the disease could potentially occur in any cat breed. This case is less relevant for adult cats or those without neurological symptoms.
In this case, the kitten’s condition progressively worsened over months despite treatment, eventually leading to refractory seizures (seizures that don’t respond to medication). The timeline from symptom onset to severe deterioration appears to be several months. Early diagnosis and treatment initiation might potentially slow progression, but this single case cannot establish realistic timelines for other affected animals.
Frequently Asked Questions
What is methylmalonic aciduria in cats and what causes it?
Methylmalonic aciduria is a rare genetic metabolic disorder where the body cannot properly process certain nutrients due to defects in cobalamin (vitamin B12) metabolism or the enzyme methylmalonyl-CoA mutase. This causes toxic metabolic byproducts to accumulate, damaging the nervous system and other organs.
What are the signs of metabolic disease in kittens?
Signs include progressive loss of coordination (ataxia), seizures, vision problems, difficulty swallowing, and muscle rigidity. These symptoms typically develop gradually over weeks to months. Any kitten showing unexplained neurological decline should be evaluated by a veterinarian with metabolic testing.
Can vitamin B12 supplements treat methylmalonic aciduria?
Vitamin B12 supplementation is a standard treatment approach, but this case shows it may not be sufficient for severe forms of the disease. The affected kitten continued deteriorating despite B12 therapy and dietary modification, suggesting some cases require additional or alternative treatments.
How is methylmalonic aciduria diagnosed in cats?
Diagnosis involves blood tests showing low vitamin B12 levels, urine tests detecting abnormal metabolic byproducts (methylmalonic acid, methylcitrate, propionylglycine), and brain imaging (MRI) showing characteristic changes like brain shrinkage and fluid accumulation.
Is methylmalonic aciduria common in domestic cats?
No, methylmalonic aciduria is extremely rare in cats. This case report is one of very few documented cases in veterinary medicine, making it difficult to establish typical outcomes or optimal treatment strategies for affected felines.
Want to Apply This Research?
- Pet owners with cats showing neurological symptoms could track: date of symptom onset, specific neurological signs observed (coordination problems, seizures, vision changes), medication doses and timing, and any changes in behavior or function. This detailed timeline helps veterinarians identify patterns and disease progression.
- If your kitten is diagnosed with a metabolic disorder, use an app to: set reminders for vitamin B12 supplementation and medications, log feeding times and dietary changes, record seizure frequency and duration, and track veterinary appointments and test results. Consistent documentation helps your vet monitor treatment effectiveness.
- Long-term monitoring should include regular veterinary check-ups with blood work to assess vitamin B12 levels and urinary metabolites, documentation of neurological symptoms and any changes, medication compliance tracking, and communication with your veterinarian about progression or improvement. This data helps guide treatment adjustments and informs prognosis.
This article describes a rare veterinary case report and is for educational purposes only. It is not a substitute for professional veterinary medical advice, diagnosis, or treatment. If your kitten shows signs of neurological problems such as loss of coordination, seizures, vision changes, or difficulty swallowing, consult your veterinarian immediately. Methylmalonic aciduria is an extremely rare condition, and most kittens with neurological symptoms have other treatable causes. Do not attempt to diagnose or treat your pet based on this information. Always work with a licensed veterinarian for proper diagnosis and treatment of your cat’s health conditions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.